Cancer preventive vaccine used in mouse model of Lynch syndrome

Bookmark and Share
Published: 15 Apr 2019
Views: 685
Rating:
Save
Prof Steven Lipkin - Weill Cornell Medical College, New York, USA

Prof Steven Lipkin speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about a study looking at the use of a cancer preventative vaccine to treat Lynch syndrome.

He explains that, in order to try and combat the disease earlier and prevent cancer, a vaccine approach was deduced.

Prof Lipkin reports that as few as four recurrent mutations were able to prevent cancer in mice with Lynch syndrome.

He reveals that a phase Ib trial has been proposed to study the use of a vaccine in Lynch syndrome patients.

Read more about this research here.